2021
DOI: 10.3389/fnagi.2021.660843
|View full text |Cite
|
Sign up to set email alerts
|

Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models

Abstract: Rare mutations in the mitochondrial protein coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2) are associated with Parkinson’s disease (PD) and other Lewy body disorders. CHCHD2 is a bi-organellar mediator of oxidative phosphorylation, playing crucial roles in regulating electron flow in the mitochondrial electron transport chain and acting as a nuclear transcription factor for a cytochrome c oxidase subunit (COX4I2) and itself in response to hypoxic stress. CHCHD2 also regulates cell migration a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
21
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(26 citation statements)
references
References 135 publications
(278 reference statements)
2
21
0
Order By: Relevance
“…Article ll OPEN ACCESS in both the DS hPSC dataset (p = 4.96 3 10 À134 ) and the FXS hPSC dataset (p = 3.68 3 10 À52 ), with dramatic downregulation observed in both disease models (Figures 3B and 2F; Tables S3 and S4). Rare mutations in CHCHD2 have been associated with several neurodegenerative diseases (Kee et al, 2021) and we noted that CHCHD2 expression levels continued to be dramatically downregulated in DS neurons, but not in FXS neurons (Tables S3 and S4). Other genes of note that were coordinately dysregulated included the protein glycosylation factor tumor suppressor candidate 3 (TUSC3), the putative magnesium transporter NIPA magnesium transporter 2 (NIPA2), the transcriptional regulator SRY-box transcription factor 11 (SOX11), and the alternative splicing regulator NOVA alternative splicing regulator 2 (NOVA2) (Figure 3B; Tables S3 and S4), all of which have been independently implicated in neurodevelopmental disorders (Garshasbi et al, 2008;Mattioli et al, 2020;Tsurusaki et al, 2014;Xie et al, 2014).…”
Section: Transcriptional Overlap Between Ds and Fxs Hpsc Modelsmentioning
confidence: 81%
See 1 more Smart Citation
“…Article ll OPEN ACCESS in both the DS hPSC dataset (p = 4.96 3 10 À134 ) and the FXS hPSC dataset (p = 3.68 3 10 À52 ), with dramatic downregulation observed in both disease models (Figures 3B and 2F; Tables S3 and S4). Rare mutations in CHCHD2 have been associated with several neurodegenerative diseases (Kee et al, 2021) and we noted that CHCHD2 expression levels continued to be dramatically downregulated in DS neurons, but not in FXS neurons (Tables S3 and S4). Other genes of note that were coordinately dysregulated included the protein glycosylation factor tumor suppressor candidate 3 (TUSC3), the putative magnesium transporter NIPA magnesium transporter 2 (NIPA2), the transcriptional regulator SRY-box transcription factor 11 (SOX11), and the alternative splicing regulator NOVA alternative splicing regulator 2 (NOVA2) (Figure 3B; Tables S3 and S4), all of which have been independently implicated in neurodevelopmental disorders (Garshasbi et al, 2008;Mattioli et al, 2020;Tsurusaki et al, 2014;Xie et al, 2014).…”
Section: Transcriptional Overlap Between Ds and Fxs Hpsc Modelsmentioning
confidence: 81%
“…The most significantly DEGs in our DS datasets were not genes encoded on HSA21. The mitochondrial and transcriptional regulator coiled-coil-helix-coiled-coil-helix domain containing 2 ( CHCHD2 ), which is a key mediator of the oxidative phosphorylation process ( Kee et al, 2021 ) and is encoded on chromosome 7, was the most significant DEG in our DS hPSC dataset, while the proteolipid neuronatin ( NNAT ) implicated in synaptic plasticity ( Joseph, 2014 ) and encoded on chromosome 20, was the most significant DEG in our DS neuron dataset ( Figure 2F ; Table S3 ). These examples highlight the striking indirect effects of HSA21 triplication, and the challenge in identifying all potentially relevant gene perturbations.…”
Section: Resultsmentioning
confidence: 99%
“…The Parkin KO mouse is a classic transgenic PD model, while there are few studies using DJ-1 KO rats [ 199 ]. Homozygous CHCHD2 KO mice mimic PD pathology in an age-dependent manner; they are indistinguishable at birth, but fragmented mitochondria in dopaminergic neurons compared to the wild type [ 200 ]. NADH ubiquinone oxidoreductase core subunit S2 (NDUFS2) is a subunit of complex I in neurons that produce dopamine.…”
Section: Diseases Linked To Mitochondrial Dysfunctionmentioning
confidence: 99%
“…The Parkin knockout mouse is a classic transgenic PD model, while there are few studies using DJ-1 knockout rats [180]. Homozygous CHCHD2 knockout mice mimic PD pathology in an age-dependent manner: indistinguishable at birth, but fragmented mitochondria in dopaminergic neurons compared to the wild type [181]. NADH:Ubiquinone Oxidoreductase Core Subunit S2 (NDUFS2) is a subunit of complex I in neurons that produce dopamine.…”
Section: Parkinson's Diseasementioning
confidence: 99%